Abstract:Phenotype modulation of pulmonary artery smooth muscle cells (PASMCs) plays an important role during hypoxia-induced vascular remodeling and pulmonary hypertension (PAH). We had previously shown that calcium-sensing receptor (CaSR) is expressed in rat PASMCs. However, little is known about the role of CaSR in phenotypic modulation of PASMCs in hypoxia-induced PAH as well as the underlying mechanisms. In this study, we investigated whether CaSR induces the proliferation of PASMCs in small pulmonary arteries from both rats and human with PAH. PAH was induced by exposing rats to hypoxia for 7–21 days. The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVI), the percentage of medial wall thickness to the external diameter (WT %), and cross-sectional total vessel wall area to the total area (WA %) of small pulmonary arteries were determined by hematoxylin and eosin (HE), masson trichrome and Weigert’s staining. The protein expressions of matrix metalloproteinase (MMP)-2 and MMP-9, the tissue inhibitors of metalloproteinase (TIMP)-3, CaSR, proliferating cell nuclear antigen (PCNA), phosphorylated extracellular signal-regulated kinase (p-ERK), and smooth muscle cell (SMC) phenotype marker proteins in rat small pulmonary arteries, including calponin, SMα-actin (SMAα), and osteopontin (OPN), were analyzed by immunohistochemistry and Western blotting, respectively. In addition, immunohistochemistry was applied to paraffin-embedded human tissues from lungs of normal human and PAH patients with chronic heart failure (PAH/CHF). Compared with the control group, mPAP, RVI, WT % and WA % in PAH rats were gradually increased with the prolonged hypoxia. At the same time, the expressions of CaSR, MMP-2, MMP-9, TIMP-3, PCNA, OPN, and p-ERK were markedly increased, while the expressions of SMAα and calponin were significantly reduced in lung tissues or small pulmonary arteries of PAH rats. Neomycin (an agonist of CaSR) enhanced but NPS2390 (an antagonist of CaSR) weakened these hypoxic effects. We further found that the expression change of CaSR, PCNA, and SMC phenotypic marker proteins in PAH/CHF lungs was similar to those in PAH rats. Our data suggest that CaSR is involved in the pulmonary vascular remodeling and PAH by promoting phenotypic modulation of small pulmonary arteries.

Advances in Researches on the Signaling Pathways for Phenotype Modulation of Pulmonary Arterial Smooth Muscle Cells in Hypoxia Pulmomary Vascular Remodeling

"Blue Lips":Research Progress in Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension

Research progress of PI3K/Akt/mTOR signal pathway on hypoxic pulmonary hypertension

Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies

The mechanism of hypoxia-induced persistent pulmonary hypertension of newborn and pulmonary vascular remodeling

Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension

Role of Oxygen Sensitive Potassium Channels in Pulmonary Arteries Smooth Muscle Cells in Hypoxic Pulmonary Vasoconstriction

Exosomes derived from hypoxic alveolar epithelial cells promote the phenotypic transformation of pulmonary artery smooth muscle cells via the Rap1 pathway

Potential Role of Cellular Senescence in Pulmonary Arterial Hypertension

Involvement of Calcium-Sensing Receptors in Hypoxia-Induced Vascular Remodeling and Pulmonary Hypertension by Promoting Phenotypic Modulation of Small Pulmonary Arteries

Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats

Stem/Progenitor Cells and Pulmonary Arterial Hypertension.

[Advances in neuromodulation of pulmonary hypertension]

Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension

Stem/Progenitor Cells And Pulmonary Arterial Hypertension

Salt-inducible Kinase 1 Deficiency Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via Enhancement of Yes-associated protein-mediated Proliferation

Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension

Anti‐apoptosis endothelial cell‐secreted microRNA‐195‐5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension

Function of pulmonary arterial fibroblasts in hypoxic pulmonary hypertension

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1<alpha> signaling pathway.